NSEShareholders meeting14 Jul 2026 · 14 Jul 2026, 07:44 pm

Shareholders meeting

Ind-Swift Laboratories Limited · INDSWFTLAB

✦ AI SummaryM&A

Ind-Swift Laboratories Limited has informed the Exchange regarding Notice of Extraordinary General Meeting to be held on August 05, 2026, to consider issuance of up to 70,00,000 fully convertible warrants to an entity belonging to the 'promoter & promoter group' on preferential basis.

Analysis Scores

Earnings Impact2/10
Growth Catalyst4/10
Governance Concern6/10
Regulatory Risk5/10
Balance Sheet Risk4/10
Liquidity Impact3/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Ind-Swift Laboratories Limited has informed the Exchange regarding Notice of Extraordinary General Meeting to be held on August 05, 2026

Attachments (1)

📄

INDSWFTLAB_14072026194317_Notice_of_EGM_Intimation.pdf

pdf

Download →
View document text
Ref: ISLL:CH:2026 Date: 14th July, 2026 The President The Vice President, Corporate Relationship Department Listing Compliance Department, BSE Limited National Stock Exchange of India Limited, Phiroze Jeejeebhoy Towers, Exchange Plaza, 5th Floor 25th Floor, Dalal Street, Plot No. C/2, G-Block, Mumbai 400 001 Bandra Kurla Complex, Bandra (E), Mumbai 400 051 BSE Scrip Code: 532305 NSE Symbol: INDSWFTLAB Subject : Notice of Extra-Ordinary General Meeting (“EGM”) of Ind-Swift Laboratories Limited (“the Company”) Dear Sir/Ma’am, Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligation & Disclosure Requirements) Regulation, 2015, as amended and any other applicable provision, we are pleased to inform that the Extra Ordinary General Meeting (“EGM”) of the Members of Ind- Swift Laboratories Limited (“the Company”) will be held on Wednesday, August 05, 2026 at 11:30 AM (IST) through Video Conferencing (“VC”) / Other Audio-Visual Means (“OAVM”). In compliance with provisions of the Companies Act, 2013, electronic copies of the Notice convening the EGM, has been dispatched by e-mail to all the Members whose e-mail addresses are registered with the Company and/or the Depository Participant. The Extra-Ordinary General Meeting Notice is also uploaded on the Company’s website at the link https://www.indswiftgroup.com/investor-relations/notice-of-agm-egm/. Pursuant to Section 108 of the Companies Act, 2013 read with Rule 20 of the Companies (Management and Administration Rules), 2014 and Regulation 44 of the SEBI (LODR) Regulations, 2015, the Company is providing the facility to its members holding shares on cut-off date i.e. Wednesday, July 29, 2026 to exercise their right to vote by electronic means on all or any of the business specified in the notice convening the EGM. (Copy enclosed) The remote e-voting will be available during the following period: Commencement of remote e-voting Sunday, 02nd August, 2026 (9:00 A.M. IST) End of remote e-voting Tuesday, 04th August, 2026 (5:00 P.M. IST) You are requested to take the same on your record. Thanking you, Yours faithfully, For IND-SWIFT LABORATORIES LTD PARDEEP VERMA VP-CORPORATE AFFAIRS & COMPANY SECRETARY IND-SWIFT LABOPRATORIES LIMITED CIN: L24232CH1995PLC015553 Registered Office: SCO:850, Shivalik Enclave, NAC, Manimajra, Chandigarh – 160101, India Email: investor@indswiftlabs.com Website: www.indswiftgroup.com Notice of Extra-Ordinary General Meeting Notice is hereby given that the 01/2026-27 Extra-Ordinary General Meeting (“EGM”) of the members of Ind-Swift Laboratories Limited ("the Company”) will be held on Wednesday, August 05, 2026, at 11:30 A.M. (IST) through video conferencing (“VC’’)/ other audio-visual means (“OAVM”) to transact the following business: SPECIAL BUSINESS: Item No. 1: ISSUANCE OF UPTO 70,00,000 FULLY CONVERTIBLE WARRANTS TO AN ENTITY BELONGING TO THE ‘PROMOTER & PROMOTER GROUP’ ON PREFERENTIAL BASIS. To consider, and if thought fit, to pass, the following resolution as Special Resolution: “RESOLVED THAT pursuant to provisions of Sections 42, 62(1)(c) and other applicable provisions, if any, of the Companies Act, 2013 (hereinafter referred to as the “Companies Act”) read with the Companies (Prospectus and Allotment of Securities) Rules, 2014, as amended and the Companies (Share Capital and Debentures) Rules, 2014, as amended and other relevant rules made there under (including any statutory modification(s) or enactment(s) or re-enactment(s) thereof, for the time being in force), enabling provisions in Memorandum and Articles of Association of the Company, provisions of uniform listing agreement entered into with National Stock Exchange of India Limited (“NSE”) and BSE Limited (“BSE”), where the equity shares of the Company are listed (collectively referred to as “Stock Exchanges”), and in accordance with the guidelines, rules and regulations of the Securities and Exchange Board of India (“SEBI”), as amended including the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended (“SEBI (ICDR) Regulations”), the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), as amended, SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 (“Takeover Regulations”) as amended, and in accordance with other applicable rules, regulations, circulars, notifications, clarifications and guidelines issued thereon, from time to time, by Ministry of Corporate Affairs, SEBI and/or any other competent authorities, and subject to approvals, consents, permissions and/or sanctions, as may be required from the Government of India, SEBI, Stock Exchanges, and any other relevant statutory, regulatory, governmental authorities or departments, institutions or bodies and subject to such terms, conditions, alterations, corrections, changes, variations and/or modifications, if any, as may be prescribed by any one or more or all of them in granting such approvals, consents, permissions and/or sanctions and which may be agreed to by Board of Directors of the Company (hereinafter referred to as the “Board” which term shall be deemed to include any Committee, which the Board has constituted or may hereafter constitute, to exercise one or more of its powers, including the powers conferred hereunder), consent of the Members of the Company be and is hereby accorded to the Board to create, issue, offer and allot, on a preferential basis, up to 70,00,000 (Seventy Lakh) Fully Convertible Warrants (“Warrants”) at an issue price of Rs. 196/- (Rupees One Hundred and Ninety-Six Only) each, determined in accordance with the provisions of Chapter V of SEBI ICDR Regulations, fully convertible at an option of Warrant holder(s) in one or more tranches, within 18 (Eighteen) months from the date of its allotment into an equivalent number of fully paid-up equity NOTICE OF EGM shares of the face value of Rs. 10 each, for cash, aggregating up to Rs. 137,20,00,000 (Rupees One Hundred Thirty-Seven Crore and Twenty Lakh Only) and to issue Fresh Equity shares on the conversion of Warrants on such further terms and conditions as may be finalized by the Board of Directors, to the below mentioned entity belonging to the ‘Promoter & Promoter Group’, for cash ("Proposed Allottee”): Sr. Name of the Proposed Allottee Category of Proposed No. of Warrants No. Allottee (up to) 1. E ssix Biosciences Limited Promoter & Promoter Group 70,00,000 Total 70,00,000 RESOLVED FURTHER THAT in terms of provisions of Chapter V of SEBI ICDR Regulations, the ‘Relevant Date’ for the purpose of determining the minimum issue price of Warrants proposed to be allotted to the above-mentioned allottee shall be Monday, July 06, 2026, i.e. being the date, which is 30 days prior to the date of Extra-ordinary general meeting i.e. Wednesday, August 05, 2026. RESOLVED FURTHER THAT aforesaid issue of Warrants shall be subject to the following terms and conditions: a) The conversion of warrants into equity shares shall happen at any time within a period of Eighteen (18) months from the date of allotment of warrants in terms of SEBI ICDR Regulations (the “Warrant Exercise Period”). b) The Proposed Allottee(s) shall, on or before the date of allotment of Warrants, pay an amount equivalent to at least 25% of the Warrant Issue Price fixed per Warrant, in terms of the SEBI ICDR Regulations, 2018, which will be kept by the Company to be adjusted and appropriated against the Warrant Issue Price of the Equity Shares. The balance of 75% of the Warrant Issue Price shall be payable by the Warrant Holder at the time of exercising the Warrants. c) Warrants being allotted to the Proposed Allottee, and the Equity Shares proposed to be allotted pursuant to the conversion of these Warrants shall be under lock-in for such period as may be prescribed under SEBI ICDR Regulations. d) Warrants so allotted under this resolution and Equity shares [Showing first 8,000 characters — download PDF for full document]